spacer_alt
spacer_alt
Referrals Clinical Trials Department Newsletter Additional Links
spacer_alt
spacer_alt
 Home
 Patient Care
 Neurosurgery Research
  (BTRC) Brain Tumor Research Center
  Aghi Laboratory
  Alvarez-Buylla Laboratory
  Bankiewicz Laboratory
  Berger Laboratory
  Bergers Laboratory
  Cha Laboratory
  Clinical Neuro-Oncology Research
  Costello Laboratory
  Gupta Laboratory
  Haas-Kogan Laboratory
  Hodgson Laboratory
  Kunwar Laboratory
  Lal Laboratory
  Parsa Laboratory
  Pieper Laboratory
  Weiss Laboratory
  Wiencke Laboratory
  Wrensch Epidemiology Group
  Program Project Grant
  SPORE Grant Projects
  PBTF Grant Projects
  PLGA Grant Projects
  (BASIC) Brain and Spinal Injury Center
  Cerebrovascular Research
  Epilepsy Research
  Movement Disorders Research
  Pain Research
  Pediatric Clinical Research
  Tissue Bank
  Research Core Facility
  Guidelines on Research Data and Reports
 Academics/Residency
 Faculty/Staff
 General Information
 Administrative Resources
Pediatric Low Grade Astrocytoma Foundation Research Award
spacer_alt
Home > Neurosurgery Research > BTRC > Pediatric Low Grade Astrocytoma Foundation Research Award
spacer_alt
   
Project Title: Targeting Cancer Stem Cells in Pediatric Fibrillary Astroctyoma
 
Principal Investigators: David Rowitch MD, PhD; C. David James PhD; Graeme Hodgson PhD
 
Program Summary*: This research project is made possible by an award granted by the Pediatric Low Grade Astrocytoma Foundation in honor of Jake Gainey (http://www.teamjake.org/). The mission of the PLGA Foundation is to "act as a central resource and a portal for information for parents, patients, families, clinicians, researchers, specialists, and other non profit institutions seeking information about Juvenile Pilocytic Astrocytoma (JPA), Pediatric Fibrillary Astrocytoma (PFA) and other forms of Pediatric Low Grade Astrocytomas (PLGA)."
 
The ultimate goal of this proposal is to change the landscape of pediatric grade II glioma (fibrillary astrocytoma) research by investigating the biological regulation of cancer stem cells.  The three specific aims of this program are as follows:
 
  • Investigate the function of OLIG2-positive stem cells in pediatric low-grade glioma

  • Develop novel mouse orthotopic models of low-grade glioma

  • Identity genes that cause diffuse low-grade astrocytomas (DLGAs), and to test the efficacy of small inhibitory nucleic acids (siNA) that target these genes in preclinical models of DLGAs

  •  
    For more information on the Pediatric Low Grade Astrocytoma Foundation, visit their Web site: http://www.fightplga.org
     
    *Adapted from fightplga.org, accessed 10/05/07
     
    UCSF UCSF Medical Center UCSF School of Medicine
    spacer_alt
    spacer_alt
    spacer_alt